{"id":"W4380083530","doi":"10.1002/hon.3164_386","title":"Matching‐adjusted indirect comparison of axicabtagene ciloleucel versus mosunetuzumab in relapsed/refractory follicular lymphoma patients after 2 prior systemic treatments","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Raincoast Conservation Foundation","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Oncology; Hazard ratio; Proportional hazards model; Fludarabine; Clinical trial; Alemtuzumab; Progression-free survival; Refractory (planetary science); Lymphoma; Overall survival; Confidence interval; Chemotherapy; Transplantation; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009124917,0.001644469,0.004803366,0.0009538147,0.0002608921,0.001438796,0.00131149,0.001501134,0.007754062],"category_scores_gemma":[0.01544847,0.0005292239,0.01370782,0.0007488892,0.0006173148,0.001047057,0.001164341,0.001908438,0.0004908913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001263183,"about_ca_system_score_gemma":0.001062721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001672241,"about_ca_topic_score_gemma":0.0019771,"domain_scores_codex":[0.9908465,0.006571564,0.0009067275,0.0008328335,0.0005243976,0.0003180848],"domain_scores_gemma":[0.9915332,0.005617907,0.001751053,0.0004389941,0.0003799514,0.0002790217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7351031,0.001206423,0.007932047,0.01800877,0.2040161,0.0000998627,0.0001477147,0.003545025,0.001155014,0.0007753288,0.0007144067,0.02729623],"study_design_scores_gemma":[0.3447209,0.1159773,0.03816256,0.002887339,0.4741854,0.0002650319,0.0002572358,0.01157039,0.002210567,0.003865476,0.005716746,0.0001810403],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8815107,0.09433398,0.005398931,0.0006433828,0.00138515,0.004565089,0.006146296,0.0001410177,0.005875546],"genre_scores_gemma":[0.9904694,0.003568645,0.001692628,0.0004014064,0.000133776,0.001613946,0.001272555,0.00001408454,0.000833603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009124917,"threshold_uncertainty_score":0.04825777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06551910042501254,"score_gpt":0.3634905538838953,"score_spread":0.2979714534588828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}